Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Probstfield

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|July 15, 1992
Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemiaH R Superko, P Greenland, R A Manchester, et al.
American Journal of Epidemiology|August 1, 1984
Coronary risk factors and exercise test performance in asymptomatic hypercholesterolemic men: application of proportional hazards analysisD J Gordon, J L Probstfield, C Rubenstein, et al.
Circulation|January 1, 1989
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studiesD J Gordon, J L Probstfield, R J Garrison, et al.
American Heart Journal|August 1, 1994
Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular DysfunctionJ B Kostis, B J Shelton, S Yusuf, et al.
Journal of the American College of Cardiology|September 1, 1989
Coronary heart disease morbidity and mortality in hypercholesterolemic men predicted from an exercise test: the Lipid Research Clinics Coronary Primary Prevention TrialL G Ekelund, C M Suchindran, R P McMahon, et al.
JAMA|July 25, 2000
Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)H M Perry, B R Davis, T R Price, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1991
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and designN O Borhani, W B Applegate, J A Cutler, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research GroupJ L Probstfield, W B Applegate, N O Borhani, et al.
Controlled Clinical Trials|May 5, 1999
Mass mailing and staff experience in a total recruitment program for a clinical trial: the SHEP experience. Systolic Hypertension in the Elderly Program. Cooperative Research GroupN Cosgrove, N O Borhani, G Bailey, et al.
Diabetologia|November 1, 2011
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trialZ Punthakee, J Bosch, G Dagenais, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|July 15, 1992
Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemiaH R Superko, P Greenland, R A Manchester, et al.
American Journal of Epidemiology|August 1, 1984
Coronary risk factors and exercise test performance in asymptomatic hypercholesterolemic men: application of proportional hazards analysisD J Gordon, J L Probstfield, C Rubenstein, et al.
Circulation|January 1, 1989
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studiesD J Gordon, J L Probstfield, R J Garrison, et al.
American Heart Journal|August 1, 1994
Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular DysfunctionJ B Kostis, B J Shelton, S Yusuf, et al.
Journal of the American College of Cardiology|September 1, 1989
Coronary heart disease morbidity and mortality in hypercholesterolemic men predicted from an exercise test: the Lipid Research Clinics Coronary Primary Prevention TrialL G Ekelund, C M Suchindran, R P McMahon, et al.
JAMA|July 25, 2000
Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)H M Perry, B R Davis, T R Price, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1991
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and designN O Borhani, W B Applegate, J A Cutler, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research GroupJ L Probstfield, W B Applegate, N O Borhani, et al.
Controlled Clinical Trials|May 5, 1999
Mass mailing and staff experience in a total recruitment program for a clinical trial: the SHEP experience. Systolic Hypertension in the Elderly Program. Cooperative Research GroupN Cosgrove, N O Borhani, G Bailey, et al.
Diabetologia|November 1, 2011
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trialZ Punthakee, J Bosch, G Dagenais, et al.
Pageof 6